Switch to optionsXpress for advanced derivatives trading & earn 50 commission-free trades.
Advertisement
SureTrader Stock Hero Advertisement
Home > Boards > US OTC > Medical - Drugs >

Entest BioMedical Inc. (ENTB)

ENTB RSS Feed
Add ENTB Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator vegasdrummer, 1-eye-jack, Kbro13
Search This Board:
Last Post: 3/31/2015 9:26:36 PM - Followers: 462 - Board type: Free - Posts Today: 0

 

 

http://www.entb.net


 

 

 

 

 

Company Information:                                                      
4700 Spring Street, Suite 304
La Mesa, Calif. 91942
Telephone: 619-644-3344
Fax: 619-330-2328
E-mail:
info@EntestBio.com

Web site: www.EntestBio.com

 

CIK 0001449447
 

ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines


 

In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)
 


Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).

Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.

Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.

Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.

 

Management: 

David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance



 

http://www.entb.net

 

 

 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTB
Current Price
Volume:
Bid Ask Day's Range
Wiki
ENTB News: Quarterly Report (10-q) 01/13/2015 06:03:03 AM
ENTB News: Annual Report (10-k) 11/26/2014 11:18:00 AM
PostSubject
#36690  Sticky Note Regen BioPharma Inc. (OTCBB: RGBP) (OTC PINK: RGBP) JokersWild12 03/24/15 11:39:41 AM
#36634  Sticky Note Value will be created at ENTB imo. sizzleweed 03/07/15 05:28:39 PM
#36753   Well one positive thing is that our Bid $tock_Killa 03/31/15 09:26:36 PM
#36752   Oh I am well aware, I just enjoy ctvette2003 03/31/15 10:38:11 AM
#36751   It's nothing. The guys been stuck in nyy13 03/31/15 10:23:41 AM
#36750   Do share Gilligan ctvette2003 03/31/15 08:30:21 AM
#36749   TODAY IS THE DAY! SKIPPERANDGILLIGAN 03/31/15 07:58:47 AM
#36748   I love the intrigue here. I am in sizzleweed 03/30/15 11:48:30 PM
#36747   Yes, risk and reward are great! for sure Brakeman 03/30/15 09:26:52 PM
#36746   Funny, this red headed step child of BMSN gotinearly 03/30/15 02:42:32 PM
#36745   So is koosy getting into the MJ field? SKIPPERANDGILLIGAN 03/30/15 01:52:55 PM
#36744   totally agree...hard to wait though. bucks2pennies 03/30/15 10:30:22 AM
#36743   B2P, precisely. Stocks such as these not for JokersWild12 03/30/15 10:28:00 AM
#36742   JW12...risk aversion? Should not be in pinkie-land bucks2pennies 03/30/15 10:17:48 AM
#36741   High risk/high reward. That's your choice as to JokersWild12 03/29/15 11:36:23 AM
#36740   One of the most daunting prospects that you Brakeman 03/29/15 10:30:24 AM
#36739   I appreciate all the feed back and positive Brakeman 03/29/15 09:54:06 AM
#36738   Thanks, I will start unloading with the big sizzleweed 03/28/15 01:58:08 PM
#36737   Nice Panda! 4 milly more to join the sizzleweed 03/28/15 01:56:18 PM
#36736   Good morning weed, panda11 03/28/15 01:14:14 PM
#36735   With this type of pumping I am satisfied Brakeman 03/28/15 08:50:27 AM
#36734   let's just hope they have the cure too! bucks2pennies 03/27/15 04:08:25 PM
#36733   It's the weekly "stickup hour" jhenmal 03/27/15 03:38:36 PM
#36732   These 3 amigos are killing me. eskimodobbs 03/27/15 03:38:14 PM
#36731   It is disappointing to see ENTB wallow in bucks2pennies 03/27/15 03:08:57 PM
#36730   1st qtr 2015..a drag for ENTB as was bucks2pennies 03/27/15 08:23:11 AM
#36729   Absolutely Lewis, patience and accumlation is the key sizzleweed 03/27/15 02:41:11 AM
#36728   Nice Lewis! We gonna lock this down. the sizzleweed 03/27/15 02:34:36 AM
#36727   Congrats, that is a nice pile! Keep loading sizzleweed 03/27/15 02:26:46 AM
#36726   How many years has it been since the Lewisinhk 03/26/15 11:43:31 PM
#36725   1% elite status here, see everyone at the Lewisinhk 03/26/15 11:20:22 PM
#36724   Good to see your still around B2P...I know $tock_Killa 03/26/15 09:57:49 PM
#36723   STOP! No one on the ENTB board manipulates bucks2pennies 03/26/15 09:29:19 PM
#36722   17+ milly for me Crocs69 03/26/15 08:44:53 PM
#36721   ENTB$$$$ U & ME. DR KOOS DR'S ICHIM. sizzleweed 03/26/15 06:17:28 PM
#36720   sweet kbro! add 4 milly more for the sizzleweed 03/26/15 06:13:06 PM
#36719   25+ milly for sizzleweed. I wonder if Jack sizzleweed 03/26/15 12:21:24 PM
#36718   sweet! round up to 24 milly and join sizzleweed 03/26/15 12:17:56 PM
#36717   20M Kbro13 03/26/15 11:35:46 AM
#36716   i have 15 million so thats 31 million SKIPPERANDGILLIGAN 03/26/15 10:22:44 AM
#36715   I have about 16,000,000 shares ChartWhisperer 03/26/15 10:18:06 AM
#36714   Thanks for the encouragement Sizzle :) Brakeman 03/25/15 08:44:07 PM
#36713   I may just buy more my friend....skips last $tock_Killa 03/25/15 07:45:16 PM
#36712   All I know is I have 1% (25 sizzleweed 03/25/15 07:28:26 PM
#36711   load up Killa, volume is increasing. This will sizzleweed 03/25/15 07:23:33 PM
#36710   Did I read that 27 million shares shorted Brakeman 03/25/15 06:37:52 PM
#36709   ebola! (haha) slb5150 03/25/15 06:15:57 PM
#36707   But it's ok to say RGBP will be SKIPPERANDGILLIGAN 03/25/15 03:36:03 PM
#36706   I wish to remain confidential. SKIPPERANDGILLIGAN 03/25/15 03:26:24 PM
#36705   Skip u got access to the NOBO list? $tock_Killa 03/25/15 02:38:25 PM
#36704   Good girl gotinearly 03/25/15 02:08:44 PM
#36703   EXACTLY! gotinearly 03/25/15 02:07:52 PM
PostSubject